The level of anti-CS response to the RTS,S/AS02A vaccine was consistent with previous studies conducted in African adults [17], [18], [20], and is generally lower than the anti-CS responses to RTS,S/AS02A in malaria-naïve adults [11], [14], [15] and in children [21], [23], [24]. This evidence concerns the gene CS and malaria.